Use of pulsatile gonadotropin-releasing hormone (GnRH) in patients with functional hypothalamic amenorrhea (FHA) results in monofollicular ovulation and high cumulative live birth rates: a 25-year cohort. The gene discussed is GNRH1; the disease is hypoalphalipoproteinemia, primary, 1.